Swapping Cigarettes for Vaping

New evidence suggests e-cigarettes are not without risks to human health, but can be useful in getting people to kick their smoking habit.

Written byAggie Mika
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

ISTOCK, RYANJLANE Kat Rose of Lakewood, Colorado, started smoking cigarettes when she was 12 years old. Ultimately, it was the smell that drove her to want to ditch the habit. “Constantly, my son was like, ‘Mom, you stink,’” she says. But quitting had been a struggle for Rose, a 30-year-old who works for a metal manufacturing company. She’s allergic to latex and cinnamon (common ingredients in nicotine patches and gum), and prescriptions like Chantix made her sick. Thanks to electronic vaporizers that emit a flavored—coconut cream pie, in Rose’s case—smoke-like cloud, “I haven’t smoked in two years,” she says.

E-cigarettes and vaporizers, devices that turn liquid concoctions into inhalable vapor, have been touted as a panacea for smokers struggling to ditch the habit. These tobacco-less substitutes mimic what it’s like to smoke conventional cigarettes but, according to some experts within the scientific community and the tobacco industry alike, they carry a fraction of the health burden and can serve as an aid for quitting tobacco cigarettes.

But researchers agree these products are not without health risks, despite messaging by some vapor product companies. One now-banned ad by a U.K.-based e-cigarette company, for example, boasted “Love your lungs”—and was censored by the Advertising Standards Authority for painting the products as healthy.

In reality, scientists are just beginning to study the effects of these vapor products ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies